Development and Characterization of Chimeric Anti-carcinoembryonic Antigen Monoclonal Antibodies and Their Fab Fragments
Open Access
- 1 March 1994
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 85 (3) , 298-305
- https://doi.org/10.1111/j.1349-7006.1994.tb02097.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cytotoxicity of chimeric (human-murine) monoclonal antibody BR96 IgG, F(ab')2, and Fab' conjugated to Pseudomonas exotoxinBioconjugate Chemistry, 1992
- Different behaviour of mouse‐human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub‐class in vivoInternational Journal of Cancer, 1992
- A Monoclonal Antibody, KM10 Reactive with Human Gastrointestinal Cancer and Its Application for ImmunotherapyJapanese Journal of Cancer Research, 1988
- Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.The Journal of Experimental Medicine, 1987
- Establishment of passive hemagglutination assay (PHA) system for anti-HBc in plasma.The Tohoku Journal of Experimental Medicine, 1986
- High-level expression of M13 gene II protein from an inducible polycistronic messenger RNAGene, 1985
- Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.Journal of Clinical Investigation, 1983
- Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphyImmunology Today, 1981
- Carcinoembryonic antigen‐like substances of human bile. Isolation and partial characterizationInternational Journal of Cancer, 1976
- Carcinoembryonic antigen (CEA) and related antigens in blood cells and hematopoietic tissuesPublished by Elsevier ,1975